BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1645956)

  • 21. Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase.
    Pan HY
    Eur J Clin Pharmacol; 1991; 40 Suppl 1():S15-8. PubMed ID: 1904355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of HMG-CoA reductase inhibitor (CS-514) on the synthesis and secretion of apolipoproteins B and A-1 in the human hepatoblastoma Hep G2.
    Sato R; Imanaka T; Takano T
    Biochim Biophys Acta; 1990 Jan; 1042(1):36-41. PubMed ID: 2153411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of rat brain prostaglandin D synthase by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Islam F; Watanabe Y; Hayaishi O
    Biochem Int; 1990 Nov; 22(4):601-5. PubMed ID: 2127671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of phospholipase D in FRTL-5 thyroid cells by forskolin and dibutyryl-cyclic adenosine monophosphate.
    Ginsberg J; Gupta S; Matowe WC; Kline L; Brindley DN
    Endocrinology; 1997 Sep; 138(9):3645-51. PubMed ID: 9275048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.
    Rakotoniaina Z; Guerard P; Lirussi F; Goirand F; Rochette L; Dumas M; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):195-206. PubMed ID: 17102939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor-I potentiates thyrotropin stimulation of adenylyl cyclase in FRTL-5 cells.
    Brenner-Gati L; Berg KA; Gershengorn MC
    Endocrinology; 1989 Sep; 125(3):1315-20. PubMed ID: 2547582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine has divergent effects on deoxyribonucleic acid synthesis in FRTL5 cells: inhibition of thyrotropin-stimulated and potentiation of insulin-like growth factor-I-stimulated thymidine incorporation.
    Moses AC; Tramontano D; Veneziani BM; Frauman AG
    Endocrinology; 1989 Nov; 125(5):2758-65. PubMed ID: 2477235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells.
    Morikawa S; Umetani M; Nakagawa S; Yamazaki H; Suganami H; Inoue K; Kitahara M; Hamakubo T; Kodama T; Saito Y
    J Atheroscler Thromb; 2000; 7(3):138-44. PubMed ID: 11480454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of geranylgeranyl pyrophosphate synthase in the proliferation of rat FRTL-5 cells: involvement of both cAMP-PKA and PI3-AKT pathways.
    Fuse M; Tanaka T; Shibata T; Yoshida T; Noguchi Y; Misawa N; Yasuda T; Saito Y; Kohn LD; Tatsuno I
    Biochem Biophys Res Commun; 2004 Mar; 315(4):1147-53. PubMed ID: 14985133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid decrease in the expression of 3-hydroxy-3-methylglutaryl-CoA reductase protein owing to inhibition of its rate of synthesis after Ca2+ mobilization in rat hepatocytes. Inability of taurolithocholate to mimic the effect.
    Zammit VA; Caldwell AM; Kolodziej MP
    Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):377-83. PubMed ID: 1953635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytosolic Ca2+ increase and cell damage in L6 rat myoblasts by HMG-CoA reductase inhibitors.
    Nakahara K; Yada T; Kuriyama M; Osame M
    Biochem Biophys Res Commun; 1994 Aug; 202(3):1579-85. PubMed ID: 8060342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypercholesterolaemia: simvastatin and pravastatin alter cholesterol metabolism by different mechanisms.
    Owens D; Collins P; Johnson A; Tighe O; Robinson K; Tomkin GH
    Biochim Biophys Acta; 1991 Apr; 1082(3):303-9. PubMed ID: 1903069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effect of LFA703, pravastatin, and fluvastatin on production of IL-18 and expression of ICAM-1 and CD40 in human monocytes.
    Takahashi HK; Mori S; Iwagaki H; Yoshino T; Tanaka N; Weitz-Schmidt G; Nishibori M
    J Leukoc Biol; 2005 Mar; 77(3):400-7. PubMed ID: 15618295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyrotropin-induced hydrogen peroxide production in FRTL-5 thyroid cells is mediated not by adenosine 3',5'-monophosphate, but by Ca2+ signaling followed by phospholipase-A2 activation and potentiated by an adenosine derivative.
    Kimura T; Okajima F; Sho K; Kobayashi I; Kondo Y
    Endocrinology; 1995 Jan; 136(1):116-23. PubMed ID: 7828520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interaction of signal transduction pathways in FRTL5 thyroid follicular cells: studies with stable expression of beta 2-adrenergic receptors.
    Tsuzaki S; Cone RD; Frazier AL; Moses AC
    Endocrinology; 1991 Mar; 128(3):1359-68. PubMed ID: 1847855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid-stimulating hormone and insulin-like growth factor-1 synergize to elevate 1,2-diacylglycerol in rat thyroid cells. Stimulation of DNA synthesis via interaction between lipid and adenylyl cyclase signal transduction systems.
    Brenner-Gati L; Berg KA; Gershengorn MC
    J Clin Invest; 1988 Sep; 82(3):1144-8. PubMed ID: 2843569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Independent and interactive effects of tetradecanoyl phorbol acetate on growth and differentiated functions of FRTL5 cells.
    Lombardi A; Veneziani BM; Tramontano D; Ingbar SH
    Endocrinology; 1988 Sep; 123(3):1544-52. PubMed ID: 2841099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin and insulin-like growth factor-I inhibit thyrotropin-increased iodide transport in serum-depleted FRTL-5 rat thyroid cells: modulation of adenosine 3',5'-monophosphate signal action.
    Saji M; Kohn LD
    Endocrinology; 1991 Feb; 128(2):1136-43. PubMed ID: 1846578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phospholipase C inhibitor, U-73122, blocks TSH-induced inositol trisphosphate production, Ca2+ increase and arachidonic acid release in FRTL-5 thyroid cells.
    Wang XD; Kiang JG; Smallridge RC
    Biochim Biophys Acta; 1994 Aug; 1223(1):101-6. PubMed ID: 8061042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of pravastatin on hepatic 3-hydroxy-3-methylglutaryl CoA reductase obtained from poloxamer 407-induced hyperlipidemic rats.
    Johnston TP; Palmer WK
    Pharmacotherapy; 1997; 17(2):342-7. PubMed ID: 9085326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.